Bertech Pharma Ltd. announced today that Dr. David Durack has joined its Scientific Advisory Board. “The addition of Dr. Durack will further diversify the outstanding talents and wide‐ranging experience that our Scientific Advisory Board already brings to Bertech,” said Mr. Bern Philip, President and CEO of Bertech Pharma. . “Dr

Bertech Pharma Ltd. announced today that Dr. David Evans and Dr. Randy Johnson have joined its Scientific Advisory Board. “The addition of Dr. Evans and Dr. Johnson to Bertech’s Scientific Board of Advisors brings significant scientific experience to Bertech and will assist in moving its cancer development programs forward,” said

Bertech Pharma has marked a significant milestone with the announcement today that the company has begun its pivitol trials on its new blood test to detect colorectal cancer. Bertech’s novel test utilizes a protein biomarker and will diagnose colorectal cancer with sensitivity greater than 80%, through a simple blood test.